Loading
Latest filing published 25 Jul 2016 for Abattis Bioceuticals Corp., €3,764.
All filings by Michael David Yung on record concern Abattis Bioceuticals Corp. Over a trading history stretching from 15 June 2016 to 30 June 2016, the count stands at 2 filings.
On the market, this insider has only ever bought: 2 purchases, €7,489 in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
Most recently, on 25 July 2016, the filings show an open-market purchase worth €3,764 in Abattis Bioceuticals Corp. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations